«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:

期数:

2015年05期

页码:

544-547

栏目:

综述

出版日期:

2015-10-15

文章信息/Info

Title:

-

作者:

周沁¹; 蒋鑫²; 吴艳²; 黄玮¹; 荆志成²

1.重庆医科大学附属第一医院心血管内科，重庆 400016 2.中国医学科学院 阜外心血管病医院心血管疾病国家重点实验室 血栓性疾病诊治中心,北京 100037

Author(s):

-

关键词:

慢性血栓栓塞性肺动脉高压; 经皮肺血管成形术

Keywords:

-

分类号:

R445.1

DOI:

-

摘要:

慢性血栓栓塞性肺动脉高压是（chronic thromboembolic pulmonary hypertension,CTEPH）由于肺动 脉内血栓机化引起的自然病程预后极差的一类疾病。肺动脉内膜剥脱术是目前CTEPH首选的治疗方法，但 是由于多种因素限制了患者该手术的临床应用。对于不能进行肺动脉剥脱术治疗的CTEPH患者，经皮肺血 管成形术是一种能够有效的改善患者症状、降低肺动脉压力及肺血管阻力并改善患者预后的新型治疗方案。

Abstract:

-

参考文献/References:

[1] Maruoka M, Sakao S, Kantake M,et al. Characterization of myofibroblasts inchronic thromboembolic pulmonary hyperten? sion.IntJ Cardiol,2012,159(2):119-127.
[2］ Becattini C, Agnelli G, esavento R,et al.Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest,2006(130):172-175.
[3］ Pengo V, Lensing AW, Prins MH,et al.Incidence of chronic thromboembolic pulmonary hypertension after pulmonary em? bolism.N EnglJ Med,2004(350):2257-2264.
[4］Wolf M, Boyer- Neumann C, Parent F,et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J,2000,15 (2):395-399.
[5］Bonderman D, Jakowitsch J, Adlbrecht C,et al.Medical con? ditions increasing the risk of chronic thromboembolic pulmo? nary hypertension.Thromb Haemost,2005,93(3):512-516.
[6］Lang IM. Chronic thromboembolic pulmonary hypertension--notso rare afterall.N EnglJ Med,2004,350(22):2236-2238.
[7］Pepke-Zaba J, Delcroix M, Lang I,et al.Chronic thrombo? embolic pulmonary hypertension(CTEPH) results from an in? ternational prospective registry ［J］．Circulation,2011,124 (18):1973-1981.
[8］Hoeper MM. Chronic thromboembolic pulmonary hyperten? sion at the crossroad［J］．Eur Respir J,2014,43(5): 1230-1232.
[9］Gregory P, Samuel ZG. Chronic thromboembolic pulmonary hypertension［J］．N EnglJ Med,2011,364(4):351-360.
[10］Kim N H, Delcroix M, Jenkins DP,etal.Chronic thromboem? bolic pulmonary hypertension［J］．J Am Coll Cardiol,2013, 62(25):D92-99.
[11］Ishiguro H, Kataoka M, Inami T,et al.Percutaneous translu? minal pulmonary angioplasty for central-type chronic thrombo? embolic pulmonary hypertension［J］．J Am Coll Cardiol Intv, 2013,6(11):1212-1213.
[12］Voorburg JA, Cats VM, Buis B,et al.Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism［J］.CHEST,1988,94(6):1249-1253.
[13］FeinsteinJA,GoldhaberSZ,LockJE,etal.Balloonpulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension［J］．Circulation,2001,103(1):10-13.
[14］Kataoka M, Inami T, Hayashida K,et al.Percutaneous trans? luminal pulmonary angioplasty for the treatment of chronicthromboembolic pulmonary hypertension ［J］．Circ Cardio? vasc Interv,2012,5(6):756-762.
[15］Mizoguchi H, Ogawa A, Munemasa M,et al.Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension ［J］．Circ Cardio? vasc Interv,2012,5(6):748-755.
[16］Sugimura K, Fukumoto Y, Satoh K,et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmo? nary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension［J］．Circ J, 2012,76(2):485-488.
[17］InamiT, Kataoka M, Shimura N,etal.Pulmonary edema pre? dictive scoring index (PEPSI), a new index to predict risk of re? perfusion pulmonary edema and improvement of hemodynam? ics in percutaneous transluminal pulmonary angioplasty［J］．J Am CollCardiolIntv,2013,6(7):725-736.
[18］Inami T, Kataoka M, Ando M,et al. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarter? ectomy and percutaneous transluminal pulmonary angioplasty ［J］．PloS one,2014,9(4):e94587.
[19］Kerr KM, Auger WR, Marsh JJ,et al.Efficacy of methylpred? nisolone in preventing lung injury following pulmonary throm? boendarterectomy［J］．Chest,2012,141(1):27-35.
[20］Ja?s X, D'Armini AM, Jansa P,et al.Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial［J］．J Am Coll Cardiol, 2008,52 (25):2127-2134.
[21］Ghofrani HA, D'Armini AM, Grimminger F,et al. Riociguat for the treatment of chronic thromboembolic pulmonary hyper? tension［J］．N EnglJ Med,2013,369(4):319-329.
[22］Simonneau G, D'Armini AM, Ghofrani HA,et al.Riociguat forthe treatment of chronic thromboembolic pulmonary hyper? tension: a long-termextension study(CHEST-2) ［J］．Eur RespirJ,2015,45(5):1293-1302.
[23］Dimopoulos K, Kempny A, Alonso-Gonzalez R,et al.Percu? taneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonaryhypertension: Challeng? es and future directions［J］．Int J Cardiol, 2015(187): 401-403.

备注/Memo

备注/Memo:

作者简介：周沁，七年制临床医学硕士，研究方向：心 血管内科 通信作者：荆志成，E-mail: jingzhichen@vip.163.com

常用功能

更新日期/Last Update: 2015-10-16